PHARMCHEM ENGINEERING PTE. LTD.

Business Description

PHARMCHEM ENGINEERING PTE. LTD. is registered as a business entity on 10 January 2005 (20.3 years ago) structured as a Exempt Private Company Limited By Shares (Local Company) with 4 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 200500426E. The business official address is located at 3018 Bedok North Street 5 #05-43, Eastlink, Singapore 486132 with main trading activity as Mechanical Engineering Works & Assembling in the primary industry of 28300: Installation Of Industrial Machinery And Equipment, Mechanical Engineering Works using Singapore Dollars - SGD as its default trading currency. The business name remains unchanged since inception. The business annual account filing date falls on 31 October and is currently operational with the status of 'Live Company'. The business paid up share capital is SGD 100,000, with preference share capital of SGD 0, and other share capital at SGD 0.

In the past 365 days, PHARMCHEM ENGINEERING PTE. LTD. has received a total of Login to view reported payment review(s). 7 were rated Good and Login to view were rated Poor. The latest review was made on 2023-04-18 and it was reported "Good". The aggregated good payment amount is equivalent to USD 5,173, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is currently active, it also signals positive financial standing. The appointment of JAS ASSURANCE as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

PHARMCHEM ENGINEERING PTE. LTD. is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023